GSK and Alector announced a strategic collaboration focused on late-stage clinical trials.
1 report, 1 independent
Updated Jul 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GSK and Alector announced a strategic collaboration focused on late-stage clinical trials.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GSK
British multinational pharmaceutical and biotechnology company
-
Alector (United States)
company in San Francisco, United States
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Simply Wall St.3 Penny Stocks With Market Caps Over $80M To Watch Closely The U.S. stock market has been navigating a wave of uncertainty, with recent tariff threats from President Trump causing fluctuations across